WhiteLab Genomics raises €9.0M Series A round
13 September 2022· Paris, France· health, genomic_medicine, ai, drug_discovery, b2b, pure_software
The funding is to advance the mission to accelerate the development of genomics medicines via technology powered by artificial intelligence (AI). It will also contribute to the growth plan of the start-up's R&D team and US operations.
Investors
LeadDebiopharm Innovation Fund
Also participating
OMNES Capital
About WhiteLab Genomics
Stage
Series A
Headquarters
Paris, France
Founded
2019
Team Size
21–50
Sectors
healthgenomic_medicineaidrug_discoveryb2bpure_software
Source: https://www.debiopharm.com/newsroom/debiopharm-co-leads-a-series-a-round-in-whitelab-genomics/